ADAG (Adagene) Long-Term Debt : $0.42 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Adagene Long-Term Debt?

Adagene's Long-Term Debt for the quarter that ended in Dec. 2024 was $0.42 Mil.

Adagene's quarterly Long-Term Debt declined from Dec. 2023 ($13.54 Mil) to Jun. 2024 ($4.56 Mil) and declined from Jun. 2024 ($4.56 Mil) to Dec. 2024 ($0.42 Mil).

Adagene's annual Long-Term Debt declined from Dec. 2022 ($14.15 Mil) to Dec. 2023 ($13.54 Mil) and declined from Dec. 2023 ($13.54 Mil) to Dec. 2024 ($0.42 Mil).

Adagene Long-Term Debt Historical Data

The historical data trend for Adagene's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagene Long-Term Debt Chart

Adagene Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

2.97

2.99

14.15

13.54

0.42

Adagene Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Long-Term Debt	Get a 7-Day Free Trial							14.15	13.35	13.54	4.56	0.42

Adagene (NAS:ADAG) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Adagene Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Adagene's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Adagene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adagene Inc (NAS:ADAG) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

978:Germany

Address

Xinghu Street, Suzhou Industrial Park, 4th Floor, Building C14, No. 218, Jiangsu Province, Suzhou, CHN, 215123

Website

https://www.adagene.com

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.